Treating Drug Problems:


Book Description

Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.




Federal Drug Control


Book Description

A comprehensive look at the beginnings of the current drug problems in the United States Federal Drug Control: The Evolution of Policy and Practice presents an overview of the key issues and key individuals responsible for the creation of the federal government’s efforts to control illegal drugs in the United States, from 1875-2001. The book focuses special attention on federal legislation that constructed the federal drug regulatory machinery and the Supreme Court cases that interpreted these laws and their implementation. An esteemed panel of scholars, including co-editor Joseph Spillane, author of Cocaine: From Medical Marvel to Modern Menace, and William B. McAllister, author of Drug Diplomacy in the Twentieth Century: An International History, traces the internal tensions between factions favoring medicalization and criminalization throughout the 20th century, examining the difficult choices that continue to be made in this ongoing debate. The central question in the government’s response to the crisis of illicit drugs in the United States has remained the same for more than 125 years: Should the government rely on educational and treatment programs or turn to the criminal justice system for answers? Federal Drug Control examines the historic turning points of the debate, including the 19th Century origins of the controversy, legislation and subsequent Supreme Court decisions in the 20th Century, international attempts at drug control agreements, and the emergence of new illicit drugs. The book also looks at the influential figures of the debate, including Levi Nutt, Lawrence Kolb, Richard Pearson Hobson, A.G. DuMez, and Harry J. Anslinger who ran the Federal Bureau of Narcotics (FBN) for more than 30 years. Federal Drug Control examines: the history of cocaine use in the 20th Century the history of marijuana use in the 20th Century the advent of psychotropic drugs in the 1960s the origins of the Harrison Narcotic Act the federal government’s efforts to limit the pharmacy profession’s control over prescription drugs and much more! Federal Drug Control: The Evolution of Policy and Practice is an essential resource for criminologists, historians, social historians, sociologists, anthropologists, public policymakers, academics, and anyone interested in the broad issues involved in how the federal government deals with the problem of illicit drugs in the United States.




Drug Law Enforcement Strategies


Book Description

Drug Law Enforcement Strategies provides an authoritative, insider's perspective on the intricacies of drug crimes, investigations, and trials. Featuring law enforcement officials from around the country, this book guides the reader through the latest trends in the narcotics arenaincluding new drugs entering the market, the medical marijuana controversy, and the role of technology in investigationswhile analyzing how these issues are impacting procedures. These skilled authors highlight proven methods for embarking on an investigation, creating drug-specific case strategies, working with informants, going undercover, and setting short- and long-term goals for an investigation. Looking at the investigator's role in bringing a drug case to court, they also explain how to supply effective evidence, work successfully with prosecutors, and anticipate questions from defense attorneys. Additionally, these leaders reveal their strategies for collaborating with other agencies, training investigators, and coping with shrinking budgets and limited manpower. The different niches represented and the breadth of perspectives presented enable readers to get inside some of the great legal minds of today, as these experienced officers offer up their thoughts on the keys to success within this ever-evolving field.




Facing Addiction in America


Book Description

All across the United States, individuals, families, communities, and health care systems are struggling to cope with substance use, misuse, and substance use disorders. Substance misuse and substance use disorders have devastating effects, disrupt the future plans of too many young people, and all too often, end lives prematurely and tragically. Substance misuse is a major public health challenge and a priority for our nation to address. The effects of substance use are cumulative and costly for our society, placing burdens on workplaces, the health care system, families, states, and communities. The Report discusses opportunities to bring substance use disorder treatment and mainstream health care systems into alignment so that they can address a person's overall health, rather than a substance misuse or a physical health condition alone or in isolation. It also provides suggestions and recommendations for action that everyone-individuals, families, community leaders, law enforcement, health care professionals, policymakers, and researchers-can take to prevent substance misuse and reduce its consequences.




Pain Management and the Opioid Epidemic


Book Description

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.




An Analytic Assessment of U.S. Drug Policy


Book Description

This book concludes that AmericaOs drug policy should be reoriented in several ways to be more effective.







More Harm Than Good


Book Description

In an era when the "war on drugs" has resulted in increasingly militarized responses from police, harsh prison sentences and overcrowded prisons, a re-examination of drug policy is sorely needed. Are prohibitive policies actually effective? In what ways do prohibitive policies affect health care, education, housing and poverty? More Harm Than Good examines the past and current state of Canadian drug policy, especially as it evolved under the Conservative government, and raises key questions about the effects of Canada's increased involvement in and commitment to the war on drugs. The analysis in this book is shaped by critical sociology and feminist perspectives and incorporates insights not only from treatment and service workers on the front lines but also from those who live with the consequences of drug policy on a daily basis: people who use criminalized drugs. The authors propose realistic alternatives to today's failed policy approach and challenge citizens and governments at all levels in Canada to chart a new course in addressing drug-related issues.




The American Disease


Book Description

The American Disease is a classic study of the development of drug laws in the United States. Supporting the theory that Americans' attitudes toward drugs have followed a cyclic pattern of tolerance and restraint, author David F. Musto examines the relationz between public outcry and the creation of prohibitive drug laws from the end of the Civil War up to the present. Originally published in 1973, and then in an expanded edition in 1987, this third edition contains a new chapter and preface that both address the renewed debate on policy and drug legislation from the end of the Reagan administration to the current Clinton administration. Here, Musto thoroughly investigates how our nation has dealt with such issues as the controversies over prevention programs and mandatory minimum sentencing, the catastrophe of the crack epidemic, the fear of a heroin revival, and the continued debate over the legalization of marijuana.




Drug Policy and the Public Good


Book Description

Illegal psychoactive substances and illicit prescription drugs are currently used on a daily basis all over the world. Affecting public health and social welfare, illicit drug use is linked to disease, disability, and social problems. Faced with an increase in usage, national and global policymakers are turning to addiction science for guidance on how to create evidence-based drug policy. Drug Policy and the Public Good is an objective analytical basis on which to build global drug policies. It presents the accumulated scientific knowledge on drug use in relation to policy development on a national and international level. By also revealing new epidemiological data on the global dimensions of drug misuse, it questions existing regulations and highlights the growing need for evidence-based, realistic, and coordinated drug policy. A critical review of cumulative scientific evidence, Drug Policy and the Public Good discusses four areas of drug policy; primary prevention programs in schools and other settings; supply reduction programs, including legal enforcement and drug interdiction; treatment interventions and harm reduction approaches; and control of the legal market through prescription drug regimes. In addition, it analyses the current state of global drug policy, and advocates improvements in the drafting of public health policy. Drug Policy and the Public Good is a global source of information and inspiration for policymakers involved in public health and social welfare. Presenting new research on illicit and prescription drug use, it is also an essential tool for academics, and a significant contribution to the translation of addiction research into effective drug policy.